WHITE PETROLATUM MINERAL OIL

WHITE PETROLATUM MINERAL OIL was reported 29 times

WHITE PETROLATUM MINERAL OIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSTILLATION SITE SWELLING 1 0.0057
1 RENAL AMYLOIDOSIS 1 0.0041
2 EYELID OPERATION 1 0.0037
3 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
4 PRODUCT CLOSURE ISSUE 1 0.0018
5 INAPPROPRIATE PRESCRIBING 1 0.0016
6 CHALAZION 1 0.0016
7 PRODUCT DESIGN ISSUE 1 0.0014
8 PORPHYRIA ACUTE 2 0.0014
9 PUNCTATE KERATITIS 1 0.0011
10 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
11 INSTILLATION SITE IRRITATION 1 0.0008
12 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
13 PRODUCT DELIVERY MECHANISM ISSUE 4 0.0007
14 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
15 SKIN WOUND 1 0.0006
16 BLINDNESS TRANSIENT 4 0.0005
17 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
18 FOREIGN BODY SENSATION IN EYES 3 0.0005
19 WRONG DOSE 1 0.0004
20 RHINALGIA 1 0.0004
21 BLEPHARITIS 1 0.0002
22 PRODUCT CONTAINER ISSUE 2 0.0002
23 VASCULAR DEVICE INFECTION 1 0.0002
24 GUILLAIN-BARRE SYNDROME 1 0.0002
25 PRODUCT USE COMPLAINT 3 0.0002
26 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
27 RIGHT VENTRICULAR FAILURE 1 0.0001
28 RASH PUSTULAR 1 0.0001
29 SENSITIVE SKIN 1 0.0001
30 SKIN SWELLING 1 0.0001
31 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
32 EYE IRRITATION 5 0.0001
33 APPLICATION SITE IRRITATION 1 0.0001
34 EXPOSURE VIA SKIN CONTACT 2 0.0001
35 TOOTH INFECTION 1 0.0001
36 SARS-COV-2 TEST POSITIVE 1 0.0001
37 EYE HAEMORRHAGE 1 0.0001
38 UVEITIS 1 0.0001
39 DRUG DISPENSING ERROR 1 0.0001
40 MULTIPLE FRACTURES 1 0.0001
41 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
42 TOOTHACHE 1 0.0001
43 END STAGE RENAL DISEASE 1 0.0001
44 EYE PAIN 3 0.0001
45 PHOTOPHOBIA 1 0.0001
46 PRODUCT PHYSICAL ISSUE 1 0.0000
47 BLINDNESS 2 0.0000
48 SEPTIC SHOCK 2 0.0000
49 PRODUCT PRESCRIBING ISSUE 1 0.0000
50 APPLICATION SITE PAIN 1 0.0000
51 PRODUCT AVAILABILITY ISSUE 1 0.0000
52 OCULAR HYPERAEMIA 2 0.0000
53 PRODUCT COMPLAINT 1 0.0000
54 MENTAL STATUS CHANGES 1 0.0000
55 EYE DISORDER 1 0.0000
56 EXPIRED PRODUCT ADMINISTERED 1 0.0000
57 LIP SWELLING 1 0.0000
58 EYE PRURITUS 1 0.0000
59 NIGHTMARE 1 0.0000
60 DRUG EFFECT INCOMPLETE 1 0.0000
61 EYE SWELLING 1 0.0000
62 ARTHRITIS 2 0.0000
63 CARDIO-RESPIRATORY ARREST 1 0.0000
64 VISION BLURRED 3 0.0000
65 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
66 PRODUCTIVE COUGH 1 0.0000
67 DRY EYE 1 0.0000
68 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
69 PRODUCT SUBSTITUTION ISSUE 1 0.0000
70 WHEEZING 1 0.0000
71 CATARACT 1 0.0000
72 VISUAL IMPAIRMENT 2 0.0000
73 RHINORRHOEA 1 0.0000
74 FEBRILE NEUTROPENIA 1 0.0000
75 BURNING SENSATION 1 0.0000
76 SKIN BURNING SENSATION 1 0.0000
77 THROMBOSIS 1 0.0000
78 CARDIAC ARREST 1 0.0000
79 SKIN EXFOLIATION 1 0.0000
80 PRODUCT STORAGE ERROR 1 0.0000
81 SOMNOLENCE 2 0.0000
82 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
83 INFLUENZA 1 0.0000
84 SEIZURE 1 0.0000
85 RENAL FAILURE 1 0.0000
86 PRODUCT QUALITY ISSUE 1 0.0000
87 NEUTROPENIA 1 0.0000
88 HYPOAESTHESIA 1 0.0000
89 ACUTE KIDNEY INJURY 1 0.0000
90 PARAESTHESIA 1 0.0000
91 CONFUSIONAL STATE 1 0.0000
92 COVID-19 1 0.0000
93 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
94 ERYTHEMA 1 0.0000
95 CONSTIPATION 1 0.0000
96 OFF LABEL USE 4 0.0000
97 ABDOMINAL PAIN 1 0.0000
98 DIZZINESS 2 0.0000
99 INSOMNIA 1 0.0000
100 CONDITION AGGRAVATED 1 0.0000
101 FALL 1 0.0000
102 PRURITUS 1 0.0000
103 NAUSEA 2 0.0000
104 ARTHRALGIA 1 0.0000
105 VOMITING 1 0.0000
106 DYSPNOEA 1 0.0000
107 DRUG INEFFECTIVE 2 0.0000
108 FATIGUE 1 0.0000
109 DEATH 1 0.0000